Go Backs
HomeCategoriesStatesCheck Your Home
Go Backs

Track product recalls and safety alerts from CPSC, FDA, NHTSA, and USDA. Stay informed and keep your family safe.

Browse

  • Categories
  • States
  • Check Your Home
  • Risk Levels

Agencies

  • CPSC
  • FDA Food
  • FDA Drug
  • FDA Device
  • FDA Veterinary
  • NHTSA
  • USDA

Company

  • About
  • FAQ
  • Contact
  • Terms of Service
  • Privacy Policy
Buy Me a Coffee

Recall data is sourced from official U.S. government agencies (CPSC, FDA, NHTSA, USDA) and processed using AI to improve readability. This site is not affiliated with or endorsed by any government agency. Always refer to the original agency notice for authoritative information.

ยฉ 2026 Go Backs. All rights reserved.

Medium RiskFDA Drug
Medications & Supplements/Prescription Drugs

Sun Pharma Medications Recalled for Potential Microbial Contamination

Agency Publication Date: January 25, 2024
Share:
Sign in to monitor this recall

Summary

Sun Pharmaceutical Industries Inc. and Ohm Laboratories are recalling 201,102 bottles of various medications, including Cinacalcet, Febuxostat, Lurasidone, Mesalamine, Niacin, Zolpidem, and Fexofenadine. The recall was issued because microbial contamination was found in stagnant water in the ducts of manufacturing equipment, violating Current Good Manufacturing Practice (CGMP). The affected medications include a variety of prescription and over-the-counter products distributed in multiple strengths and sizes across the United States.

Risk

The presence of stagnant water in manufacturing equipment creates a risk for the growth of bacteria and other microorganisms. If these contaminants enter the drug products during production, they could cause infections or other adverse health reactions, particularly in patients with weakened immune systems.

What You Should Do

  1. This recall affects various medications distributed by Sun Pharmaceutical Industries and Ohm Laboratories, including Cinacalcet, Febuxostat, Lurasidone, Mesalamine, Niacin, Zolpidem, and Fexofenadine tablets.
  2. Affected products can be identified by the NDC numbers and lot codes printed on the bottle labels, with expiration dates ranging from November 2024 to June 2026. See the Affected Products section below for the full list of affected codes.
  3. If you have health concerns, contact your healthcare provider or pharmacist. Return any unused product to the place of purchase for a refund, throw it away, or contact Sun Pharmaceutical Industries Inc. for further instructions.
  4. Call the FDA Consumer Complaint hotline at 1-888-723-3332 (1-888-SAFEFDA) for additional information.

Your Remedy Options

You have 2 options:

๐Ÿ’ฐOption 1: Full Refund
How to: Contact your healthcare provider or pharmacist for guidance, or return any unused product to the place of purchase for a refund
๐Ÿ—‘๏ธOption 2: Dispose of Product
How to: Throw the product away. For prescription medications, a DEA take-back location or pharmacy mail-back program is preferred when available.

Affected Products

Product: Cinacalcet Tablets (30 Tablets per bottle)
Variants: 60mg, Rx Only
Lot Numbers:
DNE0702A (Exp. 06/30/2026)
NDC:
47335-380-83

Distributed by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512. Manufactured by: Sun Pharmaceutical Industries Limited Survey No. 259/15, Dadra-396 191 (U.T. of D & NH), India.

Product: Febuxostat Tablets (30 Tablets per bottle)
Variants: 40mg, Rx Only
Lot Numbers:
DNE0866B (Exp. 06/30/2025)
DNE1045A
DNE1046B (Exp. 08/31/2025)
NDC:
47335-721-83

Distributed by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512. Manufactured by: Sun Pharmaceutical Industries Ltd., Survey No. 259/15, Dadra-396 191 (U.T. of D & NH), INDIA.

Product: Febuxostat Tablets (30 Tablets per bottle)
Variants: 80 mg, Rx Only
Lot Numbers:
DNE0867A (Exp. 06/30/2025)
DNE0894B (Exp. 07/31/2025)
NDC:
47335-722-83

Distributed by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512. Manufactured by: Sun Pharmaceutical Industries Ltd., Survey No. 259/15, Dadra-396 191, (U.T. of D & NH), INDIA.

Product: Lurasidone Hydrochloride Tablets (30 Tablets per bottle)
Variants: 60mg, Rx Only
Lot Numbers:
DNE0620A (Exp. 05/31/2025)
NDC:
47335-639-83

Distributed by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512. Manufactured by: Sun Pharmaceutical Industries Ltd., Survey No. 259/15, Dadra-396 191(U.T. of D & NH), INDIA.

Product: Lurasidone Hydrochloride Tablets (30 Tablets per bottle)
Variants: 120mg, Rx Only
Lot Numbers:
DNE0621A (Exp. 11/30/2024)
DNE0815A (Exp. 12/31/2024)
NDC:
47335-579-83

Distributed by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512. Manufactured by: Sun Pharmaceutical Industries Ltd., Survey No. 259/15, Dadra-396 191(U.T. of D & NH), INDIA.

Product: Mesalamine Delayed-Release Tablets (120 Tablets per bottle)
Variants: 1.2 g, Once Daily, Rx Only
Lot Numbers:
DNE0875A (Exp. 01/31/2025)
DNE0876A (Exp. 02/28/2025)
DNE0877A (Exp. 02/28/2025)
DNE1080A (Exp. 02/28/2025)
DNE1081A (Exp. 02/28/2025)
DNE1147A (Exp. 03/31/2025)
DNE1148A (Exp. 03/31/2025)
NDC:
63304-175-13

Distributed by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512. Manufactured by: Sun Pharmaceutical Industries Limited Survey No. 259/15, Dadra-396 191 (U.T. of D & NH), INDIA.

Product: Niacin Extended-Release Tablets (90 Tablets per bottle)
Variants: 1000mg, Rx Only
Lot Numbers:
DNE0788A (Exp. 07/31/2025)
NDC:
47335-613-81

Distributed by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512. Manufactured by: Sun Pharmaceutical Industries Limited, Survey No. 259/15, Dadra-396 191(U.T. of D & NH), INDIA.

Product: Niacin Extended-Release Tablets (90 Tablets per bottle)
Variants: 500mg, Rx Only
Lot Numbers:
DNE0771A (Exp. 06/30/2025)
DNE0857A (Exp. 07/31/2025)
DNE0959A (Exp. 07/31/2025)
NDC:
47335-539-81

Distributed by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512. Manufactured by: Sun Pharmaceutical Industries Limited, Survey No. 259/15, Dadra-396 191(U.T. of D & NH), INDIA.

Product: Zolpidem Tartrate Extended-Release Tablets (100 Tablets per bottle)
Variants: 6.25 mg, Rx Only
Lot Numbers:
DNE0892A (Exp. 07/31/2026)
NDC:
47335-307-88

Distributed by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512. Manufactured by: Sun Pharmaceutical Industries Limited, Survey No. 259/15, Dadra-396 191, (U.T. of D & NH), INDIA.

Product: Zolpidem Tartrate Extended-Release Tablets (100 Tablets per bottle)
Variants: 12.5mg, Rx Only
Lot Numbers:
DNE0893A (Exp. 07/31/2026)
NDC:
47335-308-88

Distributed by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512. Manufactured by: Sun Pharmaceutical Industries Limited, Survey No. 259/15, Dadra-396 191, (U.T. of D & NH), INDIA.

Product: Fexofenadine Hydrochloride Tablets (Antihistamine, Allergy, 24 hour)
Variants: 180mg, Tablet
Lot Numbers:
DNE0792A (Exp. 06/31/2025)
DNE1027A (Exp. 08/31/2025)
DNE0793A (Exp. 06/31/2025)
DNE0789A (Exp. 06/2025)
DNE0790A (Exp. 06/2025)
DNE0791A (Exp. 06/2025)
DNE1026A (Exp. 08/31/2025)
NDC:
51660-998-30
51316-800-45
51660-998-55

Distributed by: Ohm Laboratories Inc., New Brunswick, NJ 08901 and CVS Pharmacy, Inc., Woonsocket, RI 02895. Made in India.

Additional Information

Agency: Food and Drug Administration (FDA)
Event ID: 93820
Status: Resolved
Manufacturer: SUN PHARMACEUTICAL INDUSTRIES INC
Sold By: CVS Pharmacy; Ohm Laboratories Inc.
Manufactured In: India, United States
Units Affected: 11 products (1,728 bottles; 55,272 bottles; 19,992 bottles; 11,400 bottles; 9,408 bottles; 10,690 bottles; 6552 bottles; 15,768 bottles; 1220 bottles; 14,568 bottles; 54,504 bottles)
Distributed To: Nationwide

Were You Affected by This Recall?

If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.

Find an Attorney

This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.

AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.

Sources: FDA iRES ยท Raw API Response

openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.